Suchergebnisse - "Hook, Jane"

PubPharm (30)

1

Resilience Promoting Social Networks Among Unpaid Dementia Caregivers: An Exploratory Project Protocol

enthalten in: ResearchSquare.com | 2024

von Peckham, A. | Guest, M. | Pituch, K. | +3

2

Digital Interventions for Improving Pain Among Individuals With and Without Opioid Use Disorder and Reducing Medical and Non-medical Opioid Use: a Scoping Review of the Current Science

enthalten in: Current addiction reports | 2024

von Mun, C. | Hook, J. | Winsick, N. | +4

3

Diffuse cutaneous melanosis is an under-recognized sign with a poor prognosis in patients with melanoma

enthalten in: Clinical and experimental dermatology | 2023

von Coe, J. | Smith, H. | Edward, S. | +4

4

Characterisation of the onset and severity of adrenal and thyroid dysfunction associated with CTLA4-related hypophysitis

enthalten in: European journal of endocrinology | 2021

von Seejore, K. | Giannoudi, M. | Osborn, D. | +6

5

The DANTE trial protocol : a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

enthalten in: BMC cancer | 2021

von Coen, O. | Corrie, P. | Marshall, H. | +17

6

The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

enthalten in: BMC cancer | 2021

von Coen, O. | Corrie, P. | Marshall, H. | +17

7

Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8) : quality-of-life results of a phase 3, randomised, controlled trial

enthalten in: The Lancet. Oncology | 2020

von Blagden, S. | Cook, A. | Poole, C. | +16

CommentIn: Lancet Oncol. 2020 Jul;21(7):869-870. - PMID 32615101

8

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8) : primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

enthalten in: Lancet (London, England) | 2019

von Clamp, A. | James, E. | McNeish, I. | +26

CommentIn: Lancet. 2019 Dec 7;394(10214):2043-2045. - PMID 31791687

9

Are we over-treating with checkpoint inhibitors?

enthalten in: British journal of cancer | 2019

von Danson, S. | Hook, J. | Marshall, H. | +4

10

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1) : an open-label, international, randomised controlled trial

enthalten in: The Lancet. Oncology | 2016

von Marina, N. | Smeland, S. | Bielack, S. | +50

CommentIn: Lancet Oncol. 2016 Oct;17 (10 ):1340-1342. - PMID 27569441